Glioblastoma specific antigens, GD2 and CD90, are not involved in cancer stemness


Glioblastoma multiforme (GBM) is the most malignant World Health Organization grade IV brain tumor. GBM patients have a poor prognosis because of its resistance to standard therapies, such as chemotherapy and radiation. Since stem-like cells have been associated with the treatment resistance of GBM, novel therapies targeting the cancer stem cell (CSC… (More)
DOI: 10.5115/acb.2015.48.1.44

6 Figures and Tables


  • Presentations referencing similar topics